Cargando…
The alkylphospholipid, perifosine, radiosensitizes prostate cancer cells both in vitro and in vivo
BACKGROUND: Perifosine is a membrane-targeted alkylphospholipid developed to inhibit the PI3K/Akt pathway and has been suggested as a favorable candidate for combined use with radiotherapy. In this study, we investigated the effect of the combined treatment of perifosine and radiation (CTPR) on pros...
Autores principales: | Gao, Yuanhong, Ishiyama, Hiromichi, Sun, Mianen, Brinkman, Kathryn L, Wang, Xiaozhen, Zhu, Julie, Mai, Weiyuan, Huang, Ying, Floryk, Daniel, Ittmann, Michael, Thompson, Timothy C, Butler, E Brian, Xu, Bo, Teh, Bin S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096921/ https://www.ncbi.nlm.nih.gov/pubmed/21496273 http://dx.doi.org/10.1186/1748-717X-6-39 |
Ejemplares similares
-
Perifosine, a Bioavailable Alkylphospholipid Akt Inhibitor, Exhibits Antitumor Activity in Murine Models of Cancer Brain Metastasis Through Favorable Tumor Exposure
por: Taniguchi, Keisuke, et al.
Publicado: (2021) -
Long-term outcome of a moderately hypofractionated, intensity-modulated radiotherapy approach using an endorectal balloon for patients with localized prostate cancer
por: Teh, Bin S., et al.
Publicado: (2018) -
Alterations in the homeostasis of phospholipids and cholesterol by antitumor alkylphospholipids
por: Jiménez-López, José M, et al.
Publicado: (2010) -
In Vitro and In Vivo Anti-Schistosomal Activity of the Alkylphospholipid Analog Edelfosine
por: Yepes, Edward, et al.
Publicado: (2014) -
Endoplasmic reticulum targeting in Ewing's sarcoma by the alkylphospholipid analog edelfosine
por: Bonilla, Ximena, et al.
Publicado: (2015)